| ［1］ |
国家计生卫生委疾病预防控制局. 2015年全国法定传染病疫情概况［EB/OL］. （2016⁃02⁃18）［2018⁃01⁃20］. http://www.nhfpc.gov.cn/jkj/s3578/201602/b9217ba14e17452aad9e45a5bcce6b65.shtml.<br />
|
| ［2］ |
国家计生卫生委疾病预防控制局. 2016年全国法定传染病疫情概况［EB/OL］. （2017⁃02⁃23）［2018⁃01⁃20］. http://www.nhfpc.gov.cn/jkj/s3578/201702/38ca5990f8a54ddf9ca6308fec406157.shtml.<br />
|
| ［3］ |
苏兴芳, 方清艳, 杨志芳, 等. 云南省2011—2016年淋病流行趋势分析［J］.皮肤病与性病, 2017,39（4）:271⁃274. doi: 10.3969/j.issn.1002⁃1310.2017.04.017.<br />
|
| ［4］ |
Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high⁃level resistance to ceftriaxone［J］. Antimicrob Agents Chemother, 2011,55（7）:3538⁃3545. doi: 10.1128/AAC.00325⁃11.<br />
|
| ［5］ |
Newman L, Rowley J, Vander Hoorn S, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting［J］. PLoS One, 2015,10（12）:e0143304. doi: 10.1371/journal.pone.0143304.<br />
|
| ［6］ |
Lahra MM, Enriquez RP, National Neisseria Network. Australian gonococcal surveillance programme annual report, 2015［J］. Commun Dis Intell Q Rep, 2017,41（1）:E.<br />
|
| ［7］ |
Hughes G, Nichols T, Ison CA. Estimating the prevalence of gonococcal resistance to antimicrobials in England and Wales［J］. Sex Transm Infect, 2011,87（6）:526⁃31. doi: 10.1136/sextrans⁃2011⁃050071.<br />
|
| ［8］ |
Kirkcaldy RD, Harvey A, Papp JR, et al. Neisseria gonorrhoeae antimicrobial susceptibility surveillance ⁃ The Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014［J］. MMWR Surveill Summ, 2016,65（7）:1⁃19. doi: 10.15585/mmwr.ss6507a1.<br />
|
| ［9］ |
Cole MJ, Spiteri G, Jacobsson S, et al. Overall low extended⁃spectrum cephalosporin resistance but high azithromycin resistance in Neisseria gonorrhoeae in 24 European countries, 2015［J］. BMC Infect Dis, 2017,17（1）:617. doi: 10.1186/s12879⁃017⁃2707⁃z.］<br />
|
| ［10］ |
Yin YP, Han Y, Dai XQ, et al. Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: a retrospective study of national surveillance data from 2013 to 2016［J］. PLoS Med, 2018,15（2）:e1002499. doi: 10.1371/journal.pmed.1002499.<br />
|
| ［11］ |
叶顺章, 苏晓红, 王千秋, 等. 淋球菌耐药监测15年［J］. 中国性科学, 2004,（1）:1⁃3,8. doi: 10.3969/j.issn.1672⁃1993.2004.01.002.<br />
|
| ［12］ |
尹跃平. 性病防治培训手册. 实验室检测［M］. 人民卫生出版社, 2011.<br />
|
| ［13］ |
World Health Organization. WHO guidelines for the treatment of Neisseria gonorrhoeae［M］. Geneva Switzerland WHO, 2016.<br />
|
| ［14］ |
中国疾病预防控制中心性病控制中心, 中华医学会皮肤性病学分会性病学组, 中国医师协会皮肤科医师分会性病亚专业委员会. 梅毒、淋病、生殖器疱疹、生殖道沙眼衣原体感染诊疗指南（2014）［J］. 中华皮肤科杂志, 2014,47（5）:365⁃372. doi:10.3760/cma.j.issn.0412⁃4030.2014.05.022.<br />
|
| ［15］ |
Chen SC, Yin YP, Dai XQ, et al. First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China［J］. J Antimicrob Chemother, 2016,71（1）:92⁃99. doi:10.1093/jac/dkv321.<br />
|
| ［16］ |
于瑞星, 陈绍椿, 戴秀芹, 等. 淋球菌基因分型方法的研究进展［J］. 国际皮肤性病学杂志, 2014,40（3）:167⁃169. doi: 10.3760/cma.j.issn.1673⁃4173.2014.03.010.<br />
|
| ［17］ |
Graham RM, Doyle CJ, Jennison AV. Epidemiological typing of Neisseria gonorrhoeae and detection of markers associated with antimicrobial resistance directly from urine samples using next generation sequencing［J］. Sex Transm Infect, 2017,93（1）:65⁃67. doi: 10.1136/sextrans⁃2015⁃052422.<br />
|
